Nektar Therapeutics logo

NKTR

Nektar Therapeutics

Track NKTR on Kinvestor
Add it to your watchlist, get insider-buy alerts, and follow it in your portfolio — free.
About NKTR

Latest Insider Activity

Zalevsky Jonathan
Chief R&D Officer
SOLD
2026-06-15

Recent SEC Filing

All Filings →
4
4 - Zalevsky Jonathan (0001789857) (Reporting)
2026-06-17
VIEW DOC ↗

Latest NKTR News

All news →

How does NKTR stack up?

Search any stock to compare financials, market cap and sector side by side.